Dorsomorphin, a Selective Small Molecule Inhibitor of BMP Signaling, Promotes Cardiomyogenesis in Embryonic Stem Cells

Jijun Hao, Marie A. Daleo, Clare K. Murphy et al. · 2008

Read Dorsomorphin, a Selective Small Molecule Inhibitor of BMP Signaling, Promotes Cardiomyogenesis in Embryonic Stem Cells by Jijun Hao, Marie A. Daleo, Clare K. Murphy et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002904.txt.

Description

Jijun Hao, Marie Daleo, Clare Murphy and co-authors tested a small drug called dorsomorphin in stem cells in 2008. Embryonic stem cells can become any tissue type, which makes them a hopeful source for repair medicine. Guiding them into one chosen type, such as heart muscle, needs precise signals.

Dorsomorphin selectively blocks BMP signaling, one of those growth signals. In PLOS ONE the team reports that blocking BMP this way promotes cardiomyogenesis, the making of heart muscle cells, in embryonic stem cells. That gives labs a simple chemical tool for steering stem cells toward the heart.

Catalog record

CREATORJijun Hao, Marie A. Daleo, Clare K. Murphy et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002904

Browse the full library · About the Tower of Babel